Poland· PL-100256624
Buscopan forte
A butylscopolamine product containing hyoscini butylbromidum, registered in Poland by MAYOLY PHARMA FRANCE. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Butylscopolamine is registered in 11 of 19 countries.
Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Butylscopolamine · ATC A03BB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hyoscini butylbromidum
- Manufacturer
- MAYOLY PHARMA FRANCE
- Country
- Poland (PL)
- ATC code
- A03BB01
- ATC class
- Butylscopolamine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990906765
- gtin05909990906772
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03BB01
Butylscopolamine, as other registers publish it.
- CanadaACCEL-HYOSCINEACCEL PHARMA INC
- PolandAuroGastroAurovitas Pharma Polska Sp. z o.o.
- DenmarkBumacorMacure Pharma ApS
- FinlandBumacorMacure Pharma ApS
- NorwayBumacorMacure Pharma ApS
- FinlandBumofarmOrifarm Oy
- PolandBuscolysinSopharma Warszawa Sp. z o.o.
- FinlandBuscopanBoehringer Ingelheim International GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c18eaa30-574a-4d9a-b19d-91c34b8ca5bf GET /v1/drugs/c18eaa30-574a-4d9a-b19d-91c34b8ca5bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909990906765 ¦ OTC ¦ 69862\n10 tabl.\n05909990906772 ¦ OTC ¦ 69863\n20 tabl.",
"substance": "Hyoscini butylbromidum 20 mg",
"common_name": "Hyoscini butylbromidum",
"pl_product_id": "100256624",
"pozwolenie_nr": "18710",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about butylscopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.